Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

BACKGROUND: Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (Ab) in Iranian PWID before and after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Abdolhalim, Sharafi, Heidar, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825164/
https://www.ncbi.nlm.nih.gov/pubmed/33482831
http://dx.doi.org/10.1186/s12954-020-00441-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825164/
https://www.ncbi.nlm.nih.gov/pubmed/33482831
http://dx.doi.org/10.1186/s12954-020-00441-9

Ejemplares similares